KR840005665A - 면역계에 작용하는 폴리펩티드의 분리 및 정제방법 - Google Patents
면역계에 작용하는 폴리펩티드의 분리 및 정제방법 Download PDFInfo
- Publication number
- KR840005665A KR840005665A KR1019830003759A KR830003759A KR840005665A KR 840005665 A KR840005665 A KR 840005665A KR 1019830003759 A KR1019830003759 A KR 1019830003759A KR 830003759 A KR830003759 A KR 830003759A KR 840005665 A KR840005665 A KR 840005665A
- Authority
- KR
- South Korea
- Prior art keywords
- chromatography
- extract
- peptide
- separated
- filtration
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims 9
- 102000004196 processed proteins & peptides Human genes 0.000 title claims 5
- 229920001184 polypeptide Polymers 0.000 title claims 4
- 210000000987 immune system Anatomy 0.000 title claims 2
- 238000000746 purification Methods 0.000 title description 2
- 238000002955 isolation Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims 10
- 238000004587 chromatography analysis Methods 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 3
- 238000001914 filtration Methods 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 239000002244 precipitate Substances 0.000 claims 2
- 239000000047 product Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 210000001541 thymus gland Anatomy 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 239000003463 adsorbent Substances 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 229940024606 amino acid Drugs 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 238000005571 anion exchange chromatography Methods 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 230000003139 buffering effect Effects 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 238000005277 cation exchange chromatography Methods 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- 238000011210 chromatographic step Methods 0.000 claims 1
- 238000006911 enzymatic reaction Methods 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 238000002523 gelfiltration Methods 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 1
- 229910017053 inorganic salt Inorganic materials 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 239000006166 lysate Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 238000004810 partition chromatography Methods 0.000 claims 1
- 230000007030 peptide scission Effects 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000004062 sedimentation Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/837—Lymph; lymph-glands; thymus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/838—Marrow; spleen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/854—Glands
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Polyamides (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
도면 3: DEAE-셀루로즈로부터 수득한 획분을 히드록실애퍼타이트상에서 정제한 도
Claims (10)
- 침전법, 멤버레인 여과 및 크로마토그래피의 병용 도움으로 흉선으로 부터 폴리펩티드를 분리하고, 필요시 생성된 펩티드를 화학적 또는 효소적 방법에 의해 분해물로 분해시키고, 필요시 생성된 펩티드를 그의 N-아실 또는 N-아실글리실 유도체로 전환시키고, 필요시 생성물을 염으로 전환시킴을 특징으로 하여 면역계에 작용하며 분자량이 3480이고 205내지 10nm에서 최대 UV흡수를 나타내며 등전점이 3.95±0.15이고 아미노산 조성이 4아스파라긴산, 3트레오닌, 3세린, 6글루탐산, 1글리신, 4알라닌, 3발린, 1이소로이신, 1로이신, 5리신 및 1알기닌이고 필요시 N-말단이 탄소수 1내지 6의 아실그룹 또는 아실글리실그룹(여기에서 아실그룹은 1내지 6개의 탄소원자를 갖는다)을 가진 폴리펩티드, 그의 펩티드 분해산물 및 /또는 약물학적으로 허용할 수 있은 염을 분리하는 방법.
- 제1항에 있어서, 90% 이상의 순도를 가진 폴리펩티드인 방법.
- 제1항에 있어서, pH5.0내지 9.0에서 완충작용을 갖는 무기염의 수용액을 사용하여 흉선을 추출하고 불용성물질은 분리 제거하고 생성된 추출물로 부터 분리 공정에 의해 폴리펩티드를 분리시킴이 특징인 방법.
- 제1항에 있어서, 크로마토그래피단계가 양이온 및/또는 음이온 교환크로마토그래피, 비-특이성흡착제상에서의 크로마토그래피, 분배 크로마토그래피 또는 상기 방법을 2가지 이상 병용하는 것임이 특징인 방법.
- 제1항에 있어서, 펩티드는 용액에 남아 있는 반면 기타의 단백질은 침강 또는 여과로 분리제거할 수 있게 열변성시킨 추출물을 제4항에 따른 크로마토그래피에 사용함이 특징인 방법.
- 제4항에 있어서, 수-혼화성 유기용매를 제3항 또는 제5항의 추출물에 가하여 침전물로서 분리된 물질을 크로마토그래피에 사용함이 특징인 방법.
- 제4항에 있어서, 사용된 염에 따라 특정 농도에서 펩티드가 침전되고 침강법으로 농축되게 수-용성 무기 및 /또는 유기염을 가해 분열 침전시킨 추출물을 크로마토그래피에 사용함이 특징인 방법.
- 제4항에 있어서, 멤버레인 여과 및 /또는 젤여과로 분류한 결과 10,000달톤 이하의 분자량을 가진 펩티드만 여전히 함유한 추출물을 크로마토그래피에 사용함이 특징인 방법.
- 제4항에 있어서, 제5항 내지 제8항중의 어느 하나에 따른 방법을 2가지이상 병용하여 수득한 추출물-을 크로마토그래피에 사용함이 특징인 방법.
- ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP3230151.0 | 1982-08-13 | ||
DE3230151A DE3230151A1 (de) | 1982-08-13 | 1982-08-13 | Neues polypeptid mit wirkung auf das immunsystem, verfahren zu seiner isolierung und reinigung, seine verwendung, dieses enthaltende mittel sowie seine spaltprodukte, deren verwendung und diese enthaltende mittel |
Publications (1)
Publication Number | Publication Date |
---|---|
KR840005665A true KR840005665A (ko) | 1984-11-16 |
Family
ID=6170793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019830003759A KR840005665A (ko) | 1982-08-13 | 1983-08-11 | 면역계에 작용하는 폴리펩티드의 분리 및 정제방법 |
Country Status (13)
Country | Link |
---|---|
US (2) | US4500450A (ko) |
EP (1) | EP0101063B1 (ko) |
JP (1) | JPS5948422A (ko) |
KR (1) | KR840005665A (ko) |
AT (1) | ATE51628T1 (ko) |
AU (1) | AU566133B2 (ko) |
CA (1) | CA1232218A (ko) |
DE (2) | DE3230151A1 (ko) |
DK (1) | DK366783A (ko) |
ES (1) | ES8404514A1 (ko) |
IL (1) | IL69475A (ko) |
NO (1) | NO163959C (ko) |
ZA (1) | ZA835951B (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985003003A1 (en) * | 1984-01-12 | 1985-07-18 | Volker Rusch | Biologically active substance with hormonal properties, production process thereof and utilization of histones for medical purposes |
US4595588A (en) * | 1984-05-24 | 1986-06-17 | Board Of Regents, The University Of Texas System | Natural inhibitor that protects against viral infections |
AU602483B2 (en) * | 1985-01-18 | 1990-10-18 | Immunetech Pharmaceuticals | Immunoregulatory peptides |
US5817753A (en) | 1985-12-04 | 1998-10-06 | The Ohio State University Research Foundation | Antigenic modification of polypeptides |
FR2594847B1 (fr) * | 1986-02-25 | 1989-06-02 | Moet Hennessy Rech | Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant |
IT1196958B (it) * | 1986-07-10 | 1988-11-25 | Ellem Ind Farmaceutica | Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche |
IT1217314B (it) * | 1987-02-20 | 1990-03-22 | Sclavo Spa | Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale |
US5728680A (en) * | 1987-12-30 | 1998-03-17 | Cytoven J.V. | Methods for normalizing numbers of lymphocytes |
US5807830A (en) * | 1987-12-30 | 1998-09-15 | Cytoven J.V. | Method for treatment of purulent inflammatory diseases |
US5110600A (en) * | 1988-01-25 | 1992-05-05 | The Regents Of The University Of California | Method of treating viral infections with amino acid analogs |
US5811399A (en) * | 1988-12-14 | 1998-09-22 | Cytran, Inc. | Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants |
US5770576A (en) * | 1989-08-30 | 1998-06-23 | Cytran, Inc. | Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity |
US6100380A (en) * | 1991-10-28 | 2000-08-08 | Cytran, Inc. | Immunomodulating peptides and methods of use |
US6066622A (en) * | 1991-10-28 | 2000-05-23 | Cytran, Inc. | Immunomodulating peptides and methods of use |
US6458761B2 (en) | 1999-11-24 | 2002-10-01 | Lore Maria Klett-Loch | Synthetic, statistic thymic peptide combination and its use as a preparation with immunological and/or endocrinological effect |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4077949A (en) * | 1973-12-28 | 1978-03-07 | Sloan-Kettering Institute For Cancer Research | Polypeptide hormones of the thymus |
US4002602A (en) * | 1974-03-11 | 1977-01-11 | Gideon Goldstein | Ubiquitous immunopoietic polypeptide (UBIP) and methods |
US4010148A (en) * | 1975-05-12 | 1977-03-01 | Board Of Regents Of The University Of Texas System | Purified thymosin and process |
IL47645A (en) * | 1975-07-04 | 1980-10-26 | Yeda Res & Dev | Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it |
US4120951A (en) * | 1975-08-22 | 1978-10-17 | Sloan-Kettering Institute For Cancer Research | Polypeptide hormones of the thymus |
US4055633A (en) * | 1976-07-28 | 1977-10-25 | Sloan-Kettering Institute For Cancer Research | Immunoassay for thymopoietin |
US4079127A (en) * | 1976-10-28 | 1978-03-14 | Board Of Regents Of The University Of Texas | Thymosin alpha 1 |
US4297276A (en) * | 1979-03-23 | 1981-10-27 | Hoffman-La Roche Inc. | Thymosin beta 3 and beta 4 |
US4261886A (en) * | 1980-03-13 | 1981-04-14 | Ortho Pharmaceutical Corporation | Peptides having thymopoietin-like activity |
EP0033384B1 (de) * | 1980-01-18 | 1984-02-15 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente |
FR2492663B1 (fr) * | 1980-10-24 | 1985-11-08 | Vtoroi Mo G | Produit medicamenteux regulateur du t-systeme de l'immunite et son procede de preparation |
US4389343A (en) * | 1981-12-24 | 1983-06-21 | Hoffmann-La Roche Inc. | Immunopotentiating peptides from thymus |
US4388234A (en) * | 1981-12-28 | 1983-06-14 | Hoffmann-La Roche Inc. | Peptide isolation |
US4395404A (en) * | 1982-05-14 | 1983-07-26 | George Washington University | Synthetic thymosin β3 and β4 analogues |
-
1982
- 1982-08-13 DE DE3230151A patent/DE3230151A1/de not_active Withdrawn
-
1983
- 1983-08-10 AT AT83107892T patent/ATE51628T1/de not_active IP Right Cessation
- 1983-08-10 EP EP83107892A patent/EP0101063B1/de not_active Expired - Lifetime
- 1983-08-10 DE DE8383107892T patent/DE3381410D1/de not_active Expired - Fee Related
- 1983-08-11 ES ES524896A patent/ES8404514A1/es not_active Expired
- 1983-08-11 US US06/522,204 patent/US4500450A/en not_active Expired - Fee Related
- 1983-08-11 DK DK366783A patent/DK366783A/da not_active Application Discontinuation
- 1983-08-11 KR KR1019830003759A patent/KR840005665A/ko not_active Application Discontinuation
- 1983-08-12 AU AU17957/83A patent/AU566133B2/en not_active Ceased
- 1983-08-12 JP JP58146757A patent/JPS5948422A/ja active Pending
- 1983-08-12 CA CA000434452A patent/CA1232218A/en not_active Expired
- 1983-08-12 IL IL69475A patent/IL69475A/xx unknown
- 1983-08-12 ZA ZA835951A patent/ZA835951B/xx unknown
- 1983-08-12 NO NO832904A patent/NO163959C/no unknown
-
1984
- 1984-07-03 US US06/627,647 patent/US4526717A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL69475A (en) | 1986-10-31 |
NO832904L (no) | 1984-02-14 |
ES524896A0 (es) | 1984-05-01 |
DK366783D0 (da) | 1983-08-11 |
AU566133B2 (en) | 1987-10-08 |
US4500450A (en) | 1985-02-19 |
AU1795783A (en) | 1984-02-16 |
CA1232218A (en) | 1988-02-02 |
EP0101063A2 (de) | 1984-02-22 |
DK366783A (da) | 1984-02-14 |
US4526717A (en) | 1985-07-02 |
ZA835951B (en) | 1984-04-25 |
JPS5948422A (ja) | 1984-03-19 |
NO163959B (no) | 1990-05-07 |
EP0101063A3 (en) | 1986-05-14 |
DE3381410D1 (de) | 1990-05-10 |
ATE51628T1 (de) | 1990-04-15 |
ES8404514A1 (es) | 1984-05-01 |
EP0101063B1 (de) | 1990-04-04 |
NO163959C (no) | 1990-08-15 |
DE3230151A1 (de) | 1984-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Marchesi et al. | Chemical characterization and surface orientation of the major glycoprotein of the human erythrocyte membrane | |
Tuppy et al. | Study of a peptic degradation product of cytochrome-c | |
KR840005665A (ko) | 면역계에 작용하는 폴리펩티드의 분리 및 정제방법 | |
Gonzalez‐Sastre | The protein composition of isolated myelin 1 | |
Oppenheim et al. | Proline-rich proteins from human parotid saliva. I. Isolation and partial characterization | |
Sanger | Fractionation of oxidized insulin | |
Tamiya et al. | Studies on sea-snake venoms. Crystallization of erabutoxins a and b from Laticauda semifasciata venom | |
Lis et al. | Soybean hemagglutinin, a plant glycoprotein: I. isolation of a glycopeptide | |
Hunt et al. | Abnormal human haemoglobins VI. The chemical difference between haemoglobins A and E | |
Tenenbaum et al. | The preparation and characterization of water-soluble proteolipid protein from bovine brain white matter | |
Silverberg et al. | The effect of carboxymethylating a single methionine residue on the subunit interactions of glycophorin A | |
Rudman et al. | A new method for isolating the nonidentical protein subunits of human plasma α-lipoprotein | |
Tsuda | Purification and characterization of a lectin from the mushroom, Flammulina veltipes | |
Bluard-Deconinck et al. | Iron-binding fragments from the N-terminal and C-terminal regions of human lactoferrin | |
Mitsuda et al. | Purification of the 11 S component of soybean proteins | |
Meitner et al. | Bovine pepsinogens and pepsins. A series of zymogens and enzymes that differ in organic phosphate content | |
KR890701624A (ko) | 신규의 폴리펩티드 및 그 제조방법 | |
Downs et al. | Preparation of glycopeptides from bovine submaxillary mucin by chemical degradation | |
Chen et al. | Purification and characteristics of porcine growth hormone | |
Gaye et al. | In vitro synthesis of α-lactalbumin and β-lactoglobulin by microsomes and bound polyribosomes from the mammary gland of lactating sheep | |
US4430264A (en) | Process for the preparation of a selective anorexogenic substance regulating food intake | |
Kmiecik et al. | Primary structure of histone H2A from nucleated erythrocyte of the marine worm Sipunculus nudus presence of two forms of H2A in the sipunculid chromatin | |
Iwasaki et al. | Purification and Characterization of the 2 S γ2-Globulin of Normal Human Plasma | |
Bartsch et al. | The amino acid composition of the soluble chromatium haem proteins | |
Howe et al. | Immunochemical comparison of human erythrocyte membrane proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |